Michal Silverberg
InvestorManaging Director at Novartis Venture Fund
Boston, Massachusetts
Writes $5M – $10M checks · typically $7.5M
Contact· self-published, not guessed
Experience
- novartis venture fundManaging Directorcurrent2017 — present
- Takeda Ventures, Inc.Senior Partner2014 — 2017
- Novo NordiskSenior Director Business Development and New Product Commercialization2007 — 2013
- OSI PharmaceuticalsManager Business Development2006 — 2007
- MGVS (Multi Gene Vascular Systems)VP Business Development and Operation2003 — 2006
Skills & more
Clinical Development14Biotechnology15Pharmaceutical Industry23
From Michal's professional profile.
Deals · 1
ImmPACT Bio USA Inc.Board seat
via Novartis Venture Fund · filed Aug 2020 · $5.5M raise
Attribution from SEC filings, press coverage, and firm rosters.
Colleagues at Novartis Venture Fund
Aaron Nelson
Managing Director at Novartis Venture Fund
Adam Cotton
Principal at Novartis Venture Fund
Anja Koenig
Global Head of NVF at Novartis Venture Fund
Anja König
Global Head at Novartis Venture Fund
Bart Dzikowski
Managing Director, Head of Transactions & Legal at Novartis Venture Fund
Beat Steffen
Managing Director at Novartis Venture Fund
Christoph Meier
Investor at Novartis Venture Fund
Elaine Jones
Investor at Novartis Venture Fund
Frequently asked questions
- Who is Michal Silverberg?
- Managing Director at Novartis Venture Fund
- Where does Michal Silverberg work?
- Michal Silverberg is Managing Director at Novartis Venture Fund.
- What check size does Michal Silverberg write?
- Michal Silverberg typically writes checks of $5M – $10M.
- What boards does Michal Silverberg sit on?
- Michal Silverberg holds tracked board seats at ImmPACT Bio USA Inc..
- Where did Michal Silverberg go to school?
- Michal Silverberg studied at Columbia University (MA, Biotechnology); Tel Aviv University (MBA); University of Haifa (BA, Economics & Business).
Same school
Also attended Columbia University726
Ben HorowitzCo-founder & General Partner at Andreessen HorowitzDoug LeonePartner at Sequoia Capital; former Global Managing PartnerChris DixonFounder & Managing Partner of a16z crypto at Andreessen HorowitzKai-Fu LeeChairman of Sinovation Ventures and CEO of 01.AIGabriella GiglioHR & Executive Talent at General CatalystScott BillerInvestor at GV (Google Ventures)
+ 720 more
Also attended Tel Aviv University412
Matan RoetAssociate at Redpoint VenturesArnon DinurPartner at 83NorthYoram SnirPartner at 83NorthRaz MaysharSenior Manager at Qualcomm VenturesDavid GoldschmidtManaging Director, Head of the Fund at Samsung Catalyst FundAmit ShofarSr. Investment Director at Samsung Catalyst Fund
+ 406 more
Also attended University of Haifa40
Roi Bar-KatManaging Director at Intel CapitalShimon TsentsiperVenture Partner at Key1 CapitalTamir CarmiVenture Partner at PICO Venture PartnersDani GoldsherPartner and CFO at TriventuresAmir FaintuchVenture Partner at PitangoYotam DaganCo-Founder, Advisor at Vetted Accelerator
+ 34 more
Shared employers
Also worked at Takeda Ventures, Inc.5
Also worked at Novo Nordisk22
Jesper GromadaInvestor at Third Rock VenturesEmilia CarlqvistAnalyst, Innovestor Life Science at Innovestor VenturesDhiren PatelDigital Pharma Advisor at Excelerate Health VenturesBrian DanielsVenture Partner at 5AM VenturesTaruho KurodaImpact Partner at Fresco CapitalThomas NagyOperational Partner at Astanor Ventures
+ 16 more



































